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http:WHAT THIS PAPER ADDS
Vascular calciﬁcation is recognized as an independent risk factor that aggravates the prognosis of atheroscle-
rosis. Some aspects of the cause have been elucidated, but others are unclear. Calcifying nanoparticles (NPs)
have been detected recently in calciﬁed arterial specimens and are involved in the process of calciﬁcation. This
study conﬁrms the ability of human-derived calcifying NPs to accelerate hyperplasia and stimulate calciﬁcation in
previously damaged areas, and opens new lines of research for the prevention and treatment of arterial
calciﬁcation.Objective: Calcifying nanoparticles (NPs) have been detected recently in calciﬁed human arterial specimens and
are involved in the process of calciﬁcation. This study was designed to test the hypothesis that human-derived
NPs could worsen the response to arterial endothelial injury and induce vascular calciﬁcation.
Methods: The right carotid artery of 24 New Zealand rabbits was injured with an angioplasty balloon. Animals
were perfused intravenously with saline (100 mL) during the experiment and divided into three groups: group-A,
control; group-B, exposed to NPs (2 mL) obtained from calciﬁed aortic valves; and group-C, exposed to NPs (2 mL)
and treated postoperatively with atorvastatin (2.5 mg/kg/24 h). At 30 days, both carotid arteries were removed
and examined histologically. Blood measurements were monitored during the study.
Results: The intimal hyperplasia area was signiﬁcantly larger in the injured right carotid artery compared with the
left unoperated carotid artery in all groups. There was no signiﬁcant variation in medial area between groups.
Morphometrically, the intima/media ratio (IMR) was signiﬁcantly higher in damaged carotids compared with
controls. A signiﬁcant increase of IMR was found in group-B (1.81  0.41) compared with group-A (0.38  0.59;
p ¼ .004) or group-C (0.89  0.79; p ¼ .035). Differences between groups C and A were not signiﬁcant
(p ¼ .064). Calciﬁcations were observed in six animals, all of which had been exposed to NPs (4 in group-B, 2 in
group-C, p ¼ .027). Plasma levels of cholesterol and triglycerides remained stable.
Conclusions: This research conﬁrms the ability of systemic inoculation of human-derived NPs to accelerate
hyperplasia and stimulate calciﬁcation in localized areas of arteries previously submitted to endothelial damage,
while it was harmless in healthy arteries. Atorvastatin was demonstrated to slow down this process.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Vascular calciﬁcation is recognized as an active process
associated with inﬂammation that is an independent risk
factor for cardiovascular morbidity and mortality.1,2 Some
aspects of the cause of arterial calciﬁcation have been
elucidated (e.g. mechanical forces, dysregulation of mineral
metabolism, etc.), but it is unclear why some patients sufferresponding author. N. Cenizo Revuelta, Division of Vascular Surgery,
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//dx.doi.org/10.1016/j.ejvs.2014.03.002from this disorder and others do not. Nanometer scale
bacteria-like organisms (nanobacteria) have been detected
recently in calciﬁed human arteries and cardiac valves, and
are involved in the process of calciﬁcation.3e5
The term ‘nanobacteria’ was ﬁrst used and patented by
Kajander and Cifcioglu as the name for very small bacteria-
like organisms discovered in a cell culture.6,7 This new entity
is self-replicating, 0.08e0.5 mm in size, and has the capacity
to form calcium phosphate minerals under subsaturation
levels of calcium and/or phosphate. For this reason, they
have been identiﬁed as an infectious cause of pathological
calciﬁcation.8,9
At the moment, there is not enough proof that nano-
bacteria are living organisms, so they are named calcifying
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ous experimental studies that seem to conﬁrm a relation-
ship between nanoparticles and the response to arterial
damage, including arterial calciﬁcation.12
This study was designed to test the hypothesis that
human-derived nanoparticles (NPs) could worsen the
response to arterial endothelium injury and induce vascular
calciﬁcation in an animal model. As a secondary aim, based
on the pleiotropic activity of statins (mainly related to
inﬂammation and atherogenesis13,14), the therapeutic effect
of atorvastatin in the prevention of such lesions was
analyzed.
MATERIALS AND METHODS
NP culture and collection
Human NPs were obtained from calciﬁed aortic valves.
Calciﬁed valves were harvested from patients undergoing
valve replacement for symptomatic severe aortic stenosis,
following the principles outlined in the Declaration of Hel-
sinki. The valves were demineralized, ﬁltered, and cultured
according to Bratos-Pérez et al.5 After 6e8 weeks of culture,
the cells were re-suspended with the help of sterile glass
pearls and re-inoculated in new Roux ﬂasks in DMEM
(Dulbecco’s Modiﬁed Eagle Medium) supplemented with
gamma-irradiated fetal bovine serum at 37 C, under an
atmosphere with 5e10% CO2. A whitish precipitate
appeared at the bottom of the positive test tubes. These
strains have been maintained in the laboratory since then,
by way of subcultures in the same medium but without
fetal bovine serum every 8 weeks. In the successive sub-
cultures, the deposit appeared increasingly quickly and in
larger quantities. The sediment was prepared for observa-
tion under transmission electron microscopy (TEM) and
scanning electron microscopy (SEM), as explained in Bratos-
Pérez et al.5 The observation with TEM showed pleomor-
phic particles with a size of 0.2e0.5 mm. Observation with
SEM showed spherical particles grouped in clusters (Fig. 1).
Once the presence of NPs was conﬁrmed, positive sub-
cultures in Roux ﬂasks were re-suspended with the help ofFigure 1. (A) Transmission electron microscopy (TEM) showing pleom
microscopy (SEM) showing spherical particles grouped in clusters.sterile glass pearls, centrifuged, and washed with distilled
water. The resultant pellet was washed three times with
sterile phosphate-buffered saline (PBS) before preparation
for injection into animals. Finally, this solution was re-
suspended in 2 mL 0.9% NaCl. This was the ﬁnal dose
used for animal inoculation.
Animals
Twenty-four male New Zealand white rabbits (weighing
2.5e3.5 kg) were used for this study. Animals were fed with
a LabDiet rabbit chow (0.25% cholesterol) and water ad
libitum, and were maintained in individual cages (12 h light/
12 h dark cycle). All experiments were conducted in
compliance with the ‘Principles of Laboratory Animals Care’
formulated by the European Council (Directive 2010/63/EU)
and approved by the Animal Care and Bioethical Committee
of the Medical School of the Valladolid University (Spain).
Animals were divided into three groups: group-A (con-
trol), in which 100 mL of isotonic saline solution was
perfused during the experiment; group-B (treated), in which
a solution of 2 mL NPs was added to 100 mL saline solution;
and group-C (therapeutic), in which the animals perfused
with a solution of NPs, as in group-B, were treated in the
postoperative period with atorvastatin (2.5 mg/kg/24 h).
Surgical procedure
Animals were sedated intramuscularly using a mixture of
ketamine (35 mg/kg), xylazine (5 mg/kg), and acepromazine
(1 mg/kg). To avoid interferences with the NP solution,
antibiotic prophylaxis was not administered. The animals
were immobilized in supine position on the operating table.
The fur in the neck was clipped with electric shears, and the
skin was prepared with iodine solution. After local inﬁltra-
tion of mepivacaine hydrochloride (10 mg/kg), a right lat-
erocervical incision was performed to allow identiﬁcation of
the cervical vessels. The jugular vein was cannulated with
20-gauge Abocath (BD Insyte, BD Vialon Material, Sandy,
Utah, USA). A venous blood sample from the vein was
obtained (2 mL), and an intravenous infusion of isotonicorphic particles with a size of 0.2e0.5 mm. (B) Scanning electron
642 N. Cenizo Revuelta et al.saline solution of 100 mL was administered during the
experiment. Afterwards, the right carotid artery of each
animal was exposed, mobilized by gentle dissection, and
clamped proximally and distally after systemic heparin-
ization (1.5 mg/kg intravenously). The endothelium was
injured using a 3.5 mm coronary angioplasty balloon (NC
Stormer OTW 3.5  14 mm; Medtronic, Minneapolis, MN,
USA) introduced into the lumen through a small incision in
the anterior region of the carotid artery. The balloon was
inﬂated three times at nominal pressure for 30 s. Finally,
using magnifying glasses, the carotid incision was closed
with monoﬁlament suture (8-0 Ethilon, Ethicon, Johnson &
Johnson, St. Steven-Woluwe, Belgium), the microclamps
were removed, and the patency of the carotid artery was
conﬁrmed before closing the wound. The injured area was
marked by placing a small suture at the level where the
balloon had been inﬂated. The jugular venous cannula was
then removed and the vein was ligated. The contralateral
carotid artery was not exposed, serving as the unoperated
control of each animal.
NP inoculation
NP inoculation was performed during the surgical proce-
dure. Isotonic saline solution was added to the solution of
NPs from positive subcultures re-suspended in 2 mL O.9%
NaCl for a total of 100 mL, and perfused intravenously
through the right jugular catheter at a rate of approximately
2 mL/min. This dilution was administered to group-B
(treated-group) and group-C (therapeutic-group).
Histological study
At 30 days postoperation, the animals were anaesthetized
and both carotid arteries were removed, ﬁxed in formalin,
embedded in parafﬁn, sectioned, and examined histologi-
cally. A ﬁnal blood sample (2 mL) was obtained from the left
jugular vein, and the animals were killed by a lethal intra-
venous dose of sodium pentobarbital (40e60 mg/kg) at the
completion of the experiment. Specimens of tissue collec-
tion were stained with hematoxylin and eosin, elastin van
Giesen, and von Kossa to show the presence of calciﬁcation.
Slides were evaluated by light microscopy in a blinded
fashion. Finally, the images were digitized using a comput-
erized digital image analysis system mounted on the mi-
croscope (Nikon DS Camera Control Unit DS-L2). Lumen,
intima, and media borders were selected and the intimalTable 1. Blood measurements results.
Parameter A B
Basal glu (mg/dL)1 196.71  29.33 196.00
Final glu (mg/dL)2 195.43  7.76 197.86
Basal tg (mg/dL)3 54.14  26.32 47.29 
Final tg (mg/dL)4 55.83  16.16 42.83 
Basal cholest (mg/dL)5 39.57  6.24 43.14 
Final cholest (mg/dL)6 42.00  5.48 38.00 
Basal IL6 <2 <2
Final IL67 2.77  0.69 2.66 
a,b,cp > .05; dp ¼ .001.1,2,3,4,5,6,7p (A,B,C) > .05, p (B vs. C) > .05, p (and medial areas were calculated with the software. The
extent of myointimal hyperplasia was evaluated based on
intima/media ratios, considering three categories (low,
medium, and high), according to the extent of myointimal
hyperplasia in arterial cross-sections. Three sections per
stain were evaluated from each carotid artery, and the
mean value was estimated for analysis.
Blood measurements
Baseline and ﬁnal levels of cholesterol, triglycerides,
glucose, and interleukin-6 (IL-6) were determined with
commercially available kits and compared.
Statistical analysis
Statistical analysis was performed using SPSS version 17.0
(SPSS, Chicago, IL, USA). Data are expressed as
mean  standard deviation. For comparison of the cate-
gorical variables, likelihood ratio or Fisher’s exact test was
employed as necessary. The non-parametric ManneWhit-
ney U test, KruskaleWallis test, or Tukey and Dunnet test
were used to compare the continuous variables. Two-sided
nominal unadjusted p values less than .05 were considered
statistically signiﬁcant.
RESULTS
Three animals died during the postoperative period, one
from each group, leaving a total of 21 animals (7 animals
per group).
Blood measurements
There were no signiﬁcant differences between total basal
and ﬁnal blood measurements with the exception of IL-6
levels, whose ﬁnal concentration was signiﬁcantly
increased (Table 1).
Histological analysis
The uninjured artery from all animals exhibited normal
anatomy, regardless of the group assigned. By contrast, the
injured artery of rabbits showed different degrees of intimal
hyperplasia depending on the treatment received: minimal
loss of arterial wall histology was observed in four animals
of the control group (A); lesser degrees of hyperplasia were
found in ﬁve animals (2 from group-A and 3 from group-C);
greater degrees of hyperplasia were detected in anotherC Total
 19.82 196.29  17.74 169.33  21.69a
 25.17 203.86  13.77 201.06  15.87a
20.81 60.29  20.09 53.90  22.10b
12.87 60.67  11.13 54.86  17.68b
9.79 38.14  9.35 40.29  8.44c
17.32 35.71  4.23 38.57  10.56c
<2 <2d
0.59 3.07  1.30 2.89  0.95d
B/C vs. A) > .05.
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carotid artery was occluded in seven cases (1 from group-A,
4 from group-B, and 2 from group-C) (Table 2 and Fig. 2).
From these results, it seems that the degree of intimal
hyperplasia increased in those animals exposed to NPs, and
the response was decreased by the use of atorvastatin.
Calciﬁcation was only observed in the groups exposed to
NPs (4 from group-B and 2 from group-C) (Table 2).
Morphometric analysis
The intimal hyperplasia area was signiﬁcantly larger in the
injured right carotid artery compared with the left unop-
erated carotid artery in all groups (Table 3). Comparing the
injured groups of carotids, the carotid arteries in group-B
demonstrated signiﬁcant neointimal formation
(485235.94  124327 mm2) compared with group-A
(87341.08  124271; p ¼ .004) and also compared with
group-C (241536.60  181185; p ¼ .035), while group-C
showed signiﬁcantly greater hyperplasia than group-A
(p ¼ .025; Table 4 and Fig. 3).
There were no signiﬁcant differences between damaged
arteries and control unoperated arteries in relation to the
arterial media (Table 3). Moreover, there was no signiﬁcant
variation in arterial medial area between damaged groups
(A, B, C; Table 4). Therefore, the intima/media ratio was
signiﬁcantly higher in damaged carotids compared with
controls, and a signiﬁcant increase in intima/media ratio
was found in group-B (1.81  0.41) compared with the
placebo group-A (0.38  0.59; p ¼ .004) or the therapeutic
group (group-C) treated with atorvastatin (0.89  0.79;
p ¼ .035). Differences between group-C and group-A were
not signiﬁcant (p ¼ .064; Table 4 and Fig. 3).
Calciﬁcation
Positive Von Kossa staining for calcium phosphate was
identiﬁed in six animals (Fig. 2F), all of which were previ-
ously exposed to NPs: four in group-B (57%); and two in
group-C (28.5%) (Table 2). Differences between groups (A,
B, and C) were signiﬁcant (likelihood ratio, p ¼ .027).
DISCUSSION
This experimental study reinforces the hypothesis of a
positive relationship between NPs and the development of
accelerated intimal hyperplasia and calciﬁcation in a previ-
ously damaged artery. An intravenous perfusion of human-
derived NPs from calciﬁc human aortic valves leads to a
pathological process initiated by other stimuli, in this case,
mechanical endothelial denudation. In fact, the uninjured
artery from all animals, independently of the groupTable 2. Histological analysis.
Minimal loss of histology Lesser hyperp
Uninjured artery 0 0
Group-A 4 2
Group-B 0 0
Group-C 0 3assigned, exhibited normal anatomy, with a single layer of
endothelial cells, intact internal elastic lamina and media,
and an adventitia devoid of inﬂammatory cells.
Direct intra-organ injection of NPs has a proven rela-
tionship with the development of gall stones and renal
lithogenesis in experimental studies.15,16 Intravenous in-
jection of kidney stone and arterial-derived NPs were
evaluated in a preliminary study by Schwartz et al.12 They
showed in a previous experimental model of injury in
rabbit carotid arteries that NPs produced intimal hyper-
plasia and calciﬁcation, but the analysis of results was not
blinded and the histological interpretation was subjective.
In this study, we have increased the sample size; an
investigator blind to the allocation of each animal evalu-
ated the slides; and the histological analysis was per-
formed objectively by morphometric techniques. In
addition, the biochemical study showed the homogeneity
of animals, particularly with regard to plasma cholesterol
levels, which could interfere with the results by stimulating
some degree of endothelial dysfunction. There were no
signiﬁcant biochemical differences between groups, with
the exception of the IL-6 that increased in the post-
operative period, which could be related to the post-
operative inﬂammatory response to the injury. On the
other hand, the inclusion of a placebo control group
(group-A) contributed to strengthening the objectivity of
our ﬁndings, given that the carotid arteries were damaged
in the same way as in the other groups, but the animals
were perfused with an isotonic saline solution. This fact is
important to avoid bias and false positive results.
The systemic route of administration is the method that
is most similar to what occurs in reality, as NPs navigate
through the bloodstream and have the opportunity to face
the immune response of the body, which may explain some
of the variability in the vascular response observed in ani-
mals inoculated with the human-derived NPs.12 Variability
may also have resulted from the way in which inoculants
were prepared, because the method did not take into ac-
count the quality of the culture ﬂasks (the number of viable
NP colonies in each ﬂask) or the concentration of NPs per
volume administered.
The extent of intimal hyperplasia was evaluated based on
intima/media ratio. As the medial layer in all arteries
remained intact, this ratio showed modiﬁcations that were
related to the intimal response in each group. This value
was increased in group-B (1.81  0.41) compared with
group-A (0.38  0.59, p ¼ .004) and group-C (0.89  0.79,
p ¼ .035). The only factor that may explain these differ-
ences is the exposure to the calcifying human-derived NPs.
This effect of intimal thickening appears to be partly offsetlasia Greater hyperplasia Occlusion Calciﬁcation
0 0 0
0 1 0
3 4 4
2 2 2
Figure 2. Representative light micrographs of sections (5 mm) of carotid arteries of six rabbits. (A) and (B) sections are shown at 10
magniﬁcation to best show the intimal layer. (C)e(F) sections are shown at the lowest (4) magniﬁcation in order to show the entire
artery. (A)e(E) Specimens of tissue collection stained with hematoxylin and eosin. (A) Normal anatomy of arterial layers, typical of an
uninjured artery (from animal B6). (B) Minimal loss of arterial wall histology was most frequently observed in the injured right carotid
artery of animals of the control group, treated with saline (A2). (C) Example of lesser degree of hyperplasia most frequently encountered in
injured carotid of animals treated with NPs and atorvastatin (C2). (D) Example of greater degree of hyperplasia most frequently
encountered in injured carotids of animals treated only with NPs (B5). (E) Injured artery occluded, also most frequent in group-B (B4). (F)
Von Kossa stains positive for calcium phosphate identiﬁed in injured carotid of animal B5.
644 N. Cenizo Revuelta et al.by the therapeutic action of the atorvastatin. Given that the
cholesterol levels were not different between groups, the
atorvastatin could modulate the response induced in the
injured arteries, decreasing the inﬂammation.17Table 3.Morphometric analysis: comparison of parameters between th
in all groups.
Group/parameter Intimal hyperplasia mm2 (mean  SD) Me
Injured group-A 87341.08  124271.00 233
Uninjured group-A 11977.83  2972.72a 229
Injured group-B 485235.94  124327.00 269
Uninjured group-B 14256.11  5762.99b 241
Injured group-C 241536.60  18228.005 307
Uninjured group-C 14507.18  3016.1c 271
ap ¼ .006, bp ¼ .002, cp ¼ .002, dp ¼ .729, ep ¼ .082, fp ¼ .565, gpFinally, calciﬁcations were present in six animals, all of
which had been exposed to NPs. The treatment with ator-
vastatin seemed to reduce the nidi of calcium in the arterial
wall (57% group-B vs. 28.5% group-C). Although the effecte injured right carotid artery and the left un-operated carotid artery
dial area mm2 (mean  SD) Intima/media ratio (mean  SD)
556.16  92854.32 0.382  0.589
120.34  80778.54d 0.058  0.025g
322.08  44324.48 1.814  0.410
418.38  74706.75e 0.060  0.018h
000.33  82759.96 0.895  0.791
389.00  38853.86f 0.055  0.017i
¼ .006, hp ¼ .002, ip ¼ .002.
Table 4. Morphometric analysis: comparison of parameters between the injured groups of carotids.
Group/parameter Intimal hyperplasia mm2 (mean  SD)a Medial area mm2 (mean  SD)b Intima/media ratio (mean  SD)c
Group-A (placebo) 87341.08  124271 233556.16  92854.32 0.38  0.59
Group-B (treated) 485235.94  124327 269322.08  44314.49 1.81  0.41
Group-C (therapeutic) 241536.60  181185 307000.33  82759.96 0.89  0.79
a B vs. A, p ¼ .004; B vs. C, p ¼ .035; C vs. A, p ¼ .025.
b B vs. A, B vs. C and C vs. A, p > .05.
c B vs. A, p ¼ .004; C vs. A, p ¼ .035; C and A, p > .05.
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because there are studies both for and against,18e22 this
study supports a beneﬁcial effect, probably based on the
ability of statins to inhibit 3-hydroxy-3-methylglutaryl-co-
enzyme A (HMG-CoA) reductase, increasing nitric oxide
production, preventing leukocyte adhesion, or decreasing
serum osteopontin and osteoprotegerin levels.18,19 How-
ever, further investigations will be required to clarify the
potential mechanism of this drug.
Because of the slow metabolism of these self-replicating
calcifying NPs, multiple inoculations or a longer latency
period between the intravenous administration and sample
harvest might increase the number of animals that could
show calciﬁcation.17 However, our ﬁndings suggest that a
biological factor may contribute to the calciﬁcation of
arterial vessels. Vascular calciﬁcation is a multifactorial
process. There is a close relationship between the occur-
rence of pathological calciﬁcation and inﬂammation in the
process of atherosclerosis. Nevertheless, inﬂammation per
se or as an isolated entity does not explain the presence of
calciﬁcation, given that not all arteries suffer from calciﬁ-
cations. Among the various hypotheses proposed, recent
research from this Unit supports the possibility that self-
replicating calcifying NPs can contribute to such calciﬁca-
tion.5 Although the mechanism of action of NPs is not clear,
it is proposed that the NPs trigger this effect directly, given
their ability to precipitate calcium in the shape of apatite
crystals at physiological calcium and phosphate concentra-
tions, and indirectly, by activating the inﬂammatory path-
ways.1,13,23 In fact, NPs are able to infect phagocytosing
cells and have been shown to exert cytotoxic effects onFigure 3. The degree of intimal hyperplasia increased in those animals
group (A). This response was decreased by the use of atorvastatin (gro
between damaged groups (A, B, C). Therefore, the intima/media ratio w
(A) or the therapeutic group (C). Differences between groups C and Aﬁbroblasts.24,25 An infectious etiology of arterial calciﬁca-
tion is consistent with NP detection, despite its ubiquity, in
human blood and tissues (aneurysm wall, carotid plaques,
kidney stone, etc.).26 However, a deﬁnitive cause-and-effect
relationship needs to be established. In the experimental
setting, it will require infection with cultured NPs and
subsequent identiﬁcation of the particles within arterial
calciﬁcations.
This experimental study has several limitations. First,
differences in the quality of the cultures or number of viable
NPs colonies in each ﬂask were not controlled. This may
have contributed to the variability in responses among
animals.12 Second, the method of culture of NPs, including
several washes and successive subcultures, aimed to try to
ensure complete elimination of any bovine serum or
contaminant, as well as the absence of any antigen except
NP ones, but there is no absolute proof of this elimination.
Third, the action of NPs in the absence of any cholesterol in
the diet remains unknown. Fourth, the optimal dose and
duration of atorvastatin therapy must be elucidated. Finally,
it must be kept in mind that conclusions derived from an
animal model of atherosclerosis might not be identical to
what occurs in humans; therefore, any extrapolations must
be conﬁrmed by clinical studies.
In conclusion, this research conﬁrms and quantiﬁes the
ability of a systemic inoculation of human-derived calcifying
NPs to accelerate hyperplasia and stimulate calciﬁcation in
localized areas of arteries previously submitted to endo-
thelial damage. This systemic administration of NPs was
harmless in healthy arteries. As the medial layer, regardless
of the treatment applied, did not change between theexpose to NPs (groups-B and -C) in comparison with the control
up-C). There was no signiﬁcant variation in the artery medial area
as signiﬁcantly higher in group-B compared with the control group
were not signiﬁcant.
646 N. Cenizo Revuelta et al.different groups, these data suggest that the injury model
does not alter this histological structure in the arteries.
Atorvastatin demonstrated the ability to slow down the
process of worsening atherosclerosis, probably based on its
pleiotropic activity to decrease inﬂammation, as plasma
levels of cholesterol remained stable during the study.
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